FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280490138> ?p ?o ?g. }

• W4280490138 abstract "Leukemia stem cells (LSCs) are responsible for the initiation and perpetuation of acute myeloid leukemia (AML), and also represent leukemia relapse reservoirs with limited therapeutic approaches. Thus, additional treatment strategies are medical unmet needs to eliminate LSCs.Cell counting kit-8 and Annexin-V-FITC/PI assays were used to examine the interaction of chidamide and apatinib on LSC-like cell lines (CD34+CD38- KG1α and Kasumi-1 cells) and primary CD34+ AML cells. AML patient-derived xenografts were established to investigate the in vivo efficacy of the combined regimen. RNA sequencing, Glutamine uptake assay, oxygen consumption assay, and western blotting were employed to explore the molecule mechanism for the cytotoxicity of chidamide with or without apatinib against LSC-like cell lines and/or primary CD34+ AML cells.In this study, chidamide and apatinib were synergisitc to diminish cell viability and induce apoptosis in CD34+CD38- KG1α and Kasumi-1 cells and in CD34+ primary AML cells. Importantly, chidamide combined with apatinib had more powerful in reducing leukemia burden and improving prognosis than single drug alone in an AML PDX model without significant adverse effects. Chidamide cytotoxicity was associated with decreasing glutamine uptake. The therapeutic synergy of chidamide and apatinib correlated with reprogramming of energy metabolic pathways. In addition, inactivating the VEGFR function and reducing the anti-apoptotic ability of the Bcl2 family contributed to the synergism of chidamide and apatinib in CD34+CD38- KG1α cells and CD34+ primary AML cells.Chidamide in combination with apatinib might be a promising therapeutic strategy to get rid of the population of AML stem and progenitor cells, and thus provide a potentially curative option in the treatment of patients with AML, although further clinical evaluations are required to substantiate the conclusion." @default.
• W4280490138 created "2022-05-22" @default.
• W4280490138 creator A5017095652 @default.
• W4280490138 creator A5019397177 @default.
• W4280490138 creator A5019873683 @default.
• W4280490138 creator A5021089196 @default.
• W4280490138 creator A5028758276 @default.
• W4280490138 creator A5035222810 @default.
• W4280490138 creator A5045069173 @default.
• W4280490138 creator A5073976864 @default.
• W4280490138 creator A5078521996 @default.
• W4280490138 creator A5085254271 @default.
• W4280490138 date "2022-05-17" @default.
• W4280490138 modified "2023-10-09" @default.
• W4280490138 title "Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells" @default.
• W4280490138 cites W1975216289 @default.
• W4280490138 cites W2007553857 @default.
• W4280490138 cites W2014058353 @default.
• W4280490138 cites W2026996188 @default.
• W4280490138 cites W2045309078 @default.
• W4280490138 cites W2047122678 @default.
• W4280490138 cites W2067275727 @default.
• W4280490138 cites W2101689120 @default.
• W4280490138 cites W2256066116 @default.
• W4280490138 cites W2275197865 @default.
• W4280490138 cites W2276640786 @default.
• W4280490138 cites W2534349779 @default.
• W4280490138 cites W2554142171 @default.
• W4280490138 cites W2580449060 @default.
• W4280490138 cites W2585283489 @default.
• W4280490138 cites W2585315580 @default.
• W4280490138 cites W2601168549 @default.
• W4280490138 cites W2743418290 @default.
• W4280490138 cites W2749124526 @default.
• W4280490138 cites W2795208162 @default.
• W4280490138 cites W2802688581 @default.
• W4280490138 cites W2804842024 @default.
• W4280490138 cites W2892113161 @default.
• W4280490138 cites W2892220650 @default.
• W4280490138 cites W2898284215 @default.
• W4280490138 cites W2899472109 @default.
• W4280490138 cites W2902257786 @default.
• W4280490138 cites W2916911849 @default.
• W4280490138 cites W2939609429 @default.
• W4280490138 cites W2943458460 @default.
• W4280490138 cites W2945249631 @default.
• W4280490138 cites W2947108066 @default.
• W4280490138 cites W2971544885 @default.
• W4280490138 cites W2984496473 @default.
• W4280490138 cites W3008690707 @default.
• W4280490138 cites W3015450697 @default.
• W4280490138 cites W3016510951 @default.
• W4280490138 cites W3036185872 @default.
• W4280490138 cites W3048827006 @default.
• W4280490138 cites W3087490754 @default.
• W4280490138 cites W3093964219 @default.
• W4280490138 cites W3095977572 @default.
• W4280490138 cites W3111824702 @default.
• W4280490138 cites W3195747050 @default.
• W4280490138 cites W3216844644 @default.
• W4280490138 cites W4231346141 @default.
• W4280490138 cites W59174886 @default.
• W4280490138 doi "https://doi.org/10.1186/s40164-022-00282-1" @default.
• W4280490138 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35581670" @default.
• W4280490138 hasPublicationYear "2022" @default.
• W4280490138 type Work @default.
• W4280490138 citedByCount "4" @default.
• W4280490138 countsByYear W42804901382022 @default.
• W4280490138 countsByYear W42804901382023 @default.
• W4280490138 crossrefType "journal-article" @default.
• W4280490138 hasAuthorship W4280490138A5017095652 @default.
• W4280490138 hasAuthorship W4280490138A5019397177 @default.
• W4280490138 hasAuthorship W4280490138A5019873683 @default.
• W4280490138 hasAuthorship W4280490138A5021089196 @default.
• W4280490138 hasAuthorship W4280490138A5028758276 @default.
• W4280490138 hasAuthorship W4280490138A5035222810 @default.
• W4280490138 hasAuthorship W4280490138A5045069173 @default.
• W4280490138 hasAuthorship W4280490138A5073976864 @default.
• W4280490138 hasAuthorship W4280490138A5078521996 @default.
• W4280490138 hasAuthorship W4280490138A5085254271 @default.
• W4280490138 hasBestOaLocation W42804901381 @default.
• W4280490138 hasConcept C10205521 @default.
• W4280490138 hasConcept C126322002 @default.
• W4280490138 hasConcept C159912055 @default.
• W4280490138 hasConcept C201750760 @default.
• W4280490138 hasConcept C203014093 @default.
• W4280490138 hasConcept C2776694085 @default.
• W4280490138 hasConcept C2778461978 @default.
• W4280490138 hasConcept C2778729363 @default.
• W4280490138 hasConcept C2780668389 @default.
• W4280490138 hasConcept C28328180 @default.
• W4280490138 hasConcept C502942594 @default.
• W4280490138 hasConcept C71924100 @default.
• W4280490138 hasConcept C86803240 @default.
• W4280490138 hasConcept C95444343 @default.
• W4280490138 hasConceptScore W4280490138C10205521 @default.
• W4280490138 hasConceptScore W4280490138C126322002 @default.
• W4280490138 hasConceptScore W4280490138C159912055 @default.
• W4280490138 hasConceptScore W4280490138C201750760 @default.
• W4280490138 hasConceptScore W4280490138C203014093 @default.

• next